Literature DB >> 30817954

Genetic counseling, genetic testing, and risk perceptions for breast and colorectal cancer: Results from the 2015 National Health Interview Survey.

Erin Turbitt1, Megan C Roberts2, Jennifer M Taber3, Erika A Waters4, Timothy S McNeel5, Barbara B Biesecker6, William M P Klein7.   

Abstract

We examined what proportion of the U.S. population with no personal cancer history reported receiving either genetic counseling or genetic testing for cancer risk, and also the association of these behaviors with cancer risk perceptions. We used data from the 2015 National Health Interview Survey. Objective relative risk scores for breast (women) and colorectal (men and women) cancer risk were generated for individuals without a personal history of cancer. Participants' risk perceptions were compared with their objective relative risk. Of 12,631 women, 1.2% reported receiving genetic counseling and 0.8% genetic testing for hereditary breast cancer risk. Of 15,085 men and women, 0.8% reported receiving genetic counseling and 0.3% genetic testing for hereditary colorectal cancer risk. Higher breast cancer risk perception was associated with genetic counseling (OR: 4.31, 95%CI: 2.56, 7.26) and testing (OR: 3.56, 95%CI: 1.80, 7.03). Similarly, higher perception of colorectal cancer risk was associated with genetic counseling (OR: 5.04, 95%CI: 2.57, 9.89) and testing (OR: 5.92, 95%CI: 2.40, 14.63). A higher proportion of individuals with colorectal cancer risk perceptions concordant with their objective risk (vs. discordant) had undergone genetic counseling or testing for colorectal cancer risk. Concordant risk perceptions for breast cancer were not associated with breast cancer genetic counseling or testing. Given frequent dialogue about implementing population level programs involving genetic services for cancer risk, policy makers and investigators should consider the role of risk perceptions in the effectiveness and design of such programs and potential strategies for addressing inaccuracies in risk perceptions.
Copyright © 2019. Published by Elsevier Inc.

Entities:  

Mesh:

Year:  2019        PMID: 30817954      PMCID: PMC7321923          DOI: 10.1016/j.ypmed.2019.02.027

Source DB:  PubMed          Journal:  Prev Med        ISSN: 0091-7435            Impact factor:   4.018


  32 in total

1.  Unrealistic optimism in smokers: implications for smoking myth endorsement and self-protective motivation.

Authors:  Amanda J Dillard; Kevin D McCaul; William M P Klein
Journal:  J Health Commun       Date:  2006

2.  Meta-analysis of the relationship between risk perception and health behavior: the example of vaccination.

Authors:  Noel T Brewer; Gretchen B Chapman; Frederick X Gibbons; Meg Gerrard; Kevin D McCaul; Neil D Weinstein
Journal:  Health Psychol       Date:  2007-03       Impact factor: 4.267

Review 3.  ACG clinical guideline: Genetic testing and management of hereditary gastrointestinal cancer syndromes.

Authors:  Sapna Syngal; Randall E Brand; James M Church; Francis M Giardiello; Heather L Hampel; Randall W Burt
Journal:  Am J Gastroenterol       Date:  2015-02-03       Impact factor: 10.864

4.  National Estimates of Genetic Testing in Women With a History of Breast or Ovarian Cancer.

Authors:  Christopher P Childers; Kimberly K Childers; Melinda Maggard-Gibbons; James Macinko
Journal:  J Clin Oncol       Date:  2017-08-18       Impact factor: 44.544

5.  Self-affirmation moderates effects of unrealistic optimism and pessimism on reactions to tailored risk feedback.

Authors:  William M P Klein; Isaac M Lipkus; Sarah M Scholl; Amy McQueen; Jennifer L Cerully; Peter R Harris
Journal:  Psychol Health       Date:  2010-12

6.  Correlates of unrealistic risk beliefs in a nationally representative sample.

Authors:  Erika A Waters; William M P Klein; Richard P Moser; Mandi Yu; William R Waldron; Timothy S McNeel; Andrew N Freedman
Journal:  J Behav Med       Date:  2010-11-26

7.  A Primer on Unrealistic Optimism.

Authors:  James A Shepperd; Erika Waters; Neil D Weinstein; William M P Klein
Journal:  Curr Dir Psychol Sci       Date:  2015-06

8.  Demographic and psychosocial factors associated with perceived risk for colorectal cancer.

Authors:  Kathryn A Robb; Anne Miles; Jane Wardle
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2004-03       Impact factor: 4.254

9.  Resisting good news: reactions to breast cancer risk communication.

Authors:  Amanda J Dillard; Kevin D McCaul; Pamela D Kelso; William M P Klein
Journal:  Health Commun       Date:  2006

Review 10.  Is there evidence that we should screen the general population for Lynch syndrome with genetic testing? A systematic review.

Authors:  Anya E R Prince; R Jean Cadigan; Gail E Henderson; James P Evans; Michael Adams; Emmanuel Coker-Schwimmer; Dolly C Penn; Marcia Van Riper; Giselle Corbie-Smith; Daniel E Jonas
Journal:  Pharmgenomics Pers Med       Date:  2017-02-20
View more
  5 in total

1.  Prevalence of Americans reporting a family history of cancer indicative of increased cancer risk: Estimates from the 2015 National Health Interview Survey.

Authors:  Marie T Kumerow; Juan L Rodriguez; Shifan Dai; Katherine Kolor; Melissa Rotunno; Lucy A Peipins
Journal:  Prev Med       Date:  2022-04-20       Impact factor: 4.637

2.  Colorectal cancer lifetime risk accuracy and behavior change intentions before and after risk assessment.

Authors:  Carrie A Miller; Andrew J Barnes; Bernard F Fuemmeler; Maria D Thomson
Journal:  Cancer Causes Control       Date:  2021-01-29       Impact factor: 2.506

3.  Genetic Testing and/or Counseling for Colorectal Cancer by Health Insurance Type.

Authors:  Arian Mansur; Fang Zhang; Christine Y Lu
Journal:  J Pers Med       Date:  2022-07-15

4.  Association between Health Insurance Type and Genetic Testing and/or Counseling for Breast and Ovarian Cancer.

Authors:  Arian Mansur; Fang Zhang; Christine Y Lu
Journal:  J Pers Med       Date:  2022-07-31

5.  Uptake of Genetic Testing Among Patients with Cancer At Risk for Lynch Syndrome in the National Health Interview Survey.

Authors:  Ky'Era V Actkins; Swetha Srinivasan; Lisa P Spees; Erin Turbitt; Caitlin G Allen; Megan C Roberts
Journal:  Cancer Prev Res (Phila)       Date:  2021-08-02
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.